Lidoflazin

LIDOFLAZINE, 98.5% Chemische Eigenschaften,Einsatz,Produktion Methoden

• R-Sätze Betriebsanweisung:

  R22:Gesundheitsschädlich beim Verschlucken.

• S-Sätze Betriebsanweisung:

  S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.

• Chemische Eigenschaften

  WHITE TO ALMOST WHITE POWDER

• Originator

  Clinium,Janssen,W. Germany,1969

• Verwenden

  Coronary vasodilatator;Ca++ channel activator

• Verwenden

  Lidoflazine is a L-type Ca2+ channel antagonist.Also, it is derived from 1,1''-(4-Chlorobutylidene)bis(4-fluorobenzene) (C364775), which is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells.

• Definition

  ChEBI: 2-[4-[4,4-bis(4-fluorophenyl)butyl]-1-piperazinyl]-N-(2,6-dimethylphenyl)acetamide is a diarylmethane.

• Manufacturing Process

  A mixture of 6.6 parts 1-[4,4-di-(4-fluoro-phenyl)butyl]-piperazine, 4.33 parts N-(2-chloro-acetyl)-2,6-dimethyl-aniline, 3.2 parts sodium carbonate, a few crystals of potassium iodide in 200 parts 4-methyl-2-pentanone is stirred and refluxed for 70 hours. After cooling there are added 70 parts water. The organic layer is separated, dried over potassium carbonate, filtered and evaporated. The oily residue is dissolved in 80 parts diisopropylether and the solution is filtered hot. After cooling the filtrate at 0°C. the formed solid is filtered off and recystallired from 80 parts ether, yielding 1-[4,4-di-(4-fluorophenyl)butyl]-4-[(2,6-dimethylanilino-carbonyl)-methyl]-piperazine; MP 159°C to 161°C.

• Trademarks

  Angex (Janssen); Clinium (Ortho-McNeil).

• Therapeutic Function

  Coronary vasodilator

LIDOFLAZINE, 98.5% Upstream-Materialien And Downstream Produkte

Lidoflazin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(30)Suppliers

3416-26-0, LIDOFLAZINE, 98.5% Verwandte Suche: